Found 0 matching trials
Substudy 06E: Umbrella Study of Combination Therapies in Esophageal Cancer (MK-3475-06E/KEYMAKER-U06) PHASE1 Researchers are looking for new ways to treat esophageal squamous cell carc...
Show More Location
UPMC Hillman Cancer Center ( Site 1904)
Learn More & Join Trial
PERMAD: Personalized Marker-driven Early Switch to Aflibercept in Patients With Metastatic Colorectal Cancer PHASE2 The primary objective of the two phase PERMAD trial is the evaluation of th...
Show More Location
University Medical Center Hamburg-Eppendorf
Learn More & Join Trial
Safety and Effectiveness Study of Chemotherapy and Ziv-aflibercept to Treat Metastatic Colorectal Cancer PHASE2 FC-8 is a Phase II, multi-center randomized study of a continuation regimen...
Show More Location
Multiple Locations
Learn More & Join Trial
Achievement of Improved Survival by Molecular Targeted Chemotherapy and Liver Resection for Not Optimally Resectable Colorectal Liver Metastases PHASE2 The purpose of this study is to evaluate efficacy and safety of mFOLFOX6+be...
Show More Learn More & Join Trial
A Safety and Efficacy Study of ZW25 (Zanidatamab) Plus Combination Chemotherapy in HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer PHASE2 This is a multicenter, global, Phase 2, open-label, 2-part, first-line stud...
Show More Location
USC/Norris Comprehensive Cancer Center
Learn More & Join Trial
Neoadjuvant Chemotherapy Verse Surgery Alone After Stent Placement for Obstructive Colonic Cancer NA Colorectal cancer is the fourth most common cancer in China. Up to 30% of p...
Show More Location
Beijing Chaoyang Hospital, Capital Medical University
Learn More & Join Trial
Total Neoadjuvant Treatment With or Without Tislelizumab for Locally Advanced Rectal Cancer. PHASE2 This prospective, multi-center, phase II randomized controlled trial will e...
Show More Location
Johannes Gutenberg-University Clinic, Mainz, Germany 1.Dept. Medicine, Prof. Peter R. Galle
Learn More & Join Trial
Randomized Study Of Sunitinib Plus FOLFOX Versus Bevacizumab Plus FOLFOX In Metastatic Colorectal Cancer PHASE2 This study will compare the safety and efficacy of sunitinib in combination...
Show More Location
Pfizer Investigational Site
Learn More & Join Trial
Panitumumab and RAS, Diagnostically-useful Gene Mutation for mCRC PHASE3 The purpose of this study is to verify the efficacy of mFOLFOX6 + panitumum...
Show More Location
Multiple Locations
Learn More & Join Trial
Study Comparing Optimized 5-FU Dosing and Standard Dosing in Metastatic Colorectal Cancer Patients Treated With mFOLFOX6 PHASE4 The purpose of this study is to compare OnDose® based pharmacokinetic admin...
Show More Location
Multiple Locations
Learn More & Join Trial